MPM Bio IV NVS Strategic Fund is focused on investments in companies based in the biotechnology industry.
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Apr 25, 2013
Radius Health
|
Private Equity(PE) | $43M | Biotechnology | — |
May 28, 2009
Proteon Therapeutics
|
Series B | $50M | Biotechnology | — |
Nov 20, 2008
Radius Health
|
Series C | $15M | Biotechnology | Yes |
Sep 17, 2007
Radius Health
|
Series C | $10M | Biotechnology | Yes |
May 5, 2005
AVEO Oncology
|
Series C | $5M | Biotechnology | — |
MPM Bio IV NVS Strategic Fund has had 3 exits. MPM Bio IV NVS Strategic Fund most notable exits include Proteon Therapeutics , Radius Health
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Nov 25, 2014 | Proteon Therapeutics | IPO | Biotechnology | Detail |
Jun 9, 2014 | Radius Health | M&A | Biotechnology | Detail |
Mar 12, 2010 | AVEO Oncology | M&A | Biotechnology | Detail |